PATRICIA ESTES: Open Payments
NPI 1235768037 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 45 payments from 11 companies in 2025. Trend: 2023 $480 · 2024 $1,206 · 2025 $950
Food & beverage: $861Education: $89
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $178 |
| Teva Pharmaceuticals USA, Inc. | 3 | $123 |
| Supernus Pharmaceuticals, Inc. | 20 | $122 |
| Axsome Therapeutics, Inc. | 1 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Sumitomo Pharma America, Inc. | 1 | $89 |
| Corium, LLC | 5 | $89 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| Lundbeck LLC | 2 | $40 |
| BeOne Medicines USA, Inc. | 1 | $24 |
Products named: CAPLYTA, REXULTI, Qelbree, Auvelity, MYFEMBREE, Azstarys, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
